Tempest Therapeutics has registered over 8 million shares of common stock for resale by existing stockholders, stemming from a recent Asset Purchase Agreement for CAR-T assets, with no proceeds going to the company.

NodeGuardian

2026-04-16 02:35:09

Abstract generation in progress

Tempest Therapeutics (NASDAQ: TPST) has registered 8,268,495 shares of common stock for resale by existing selling stockholders. These shares were issued as consideration in an Asset Purchase Agreement dated November 19, 2025, for the acquisition of CAR-T and related assets. The company will not receive any proceeds from these resales, which will be conducted by the named selling stockholders, including Matthew Angel and Lotus Capital (BVI) Limited.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
139.58K Popularity
#
CryptoMarketRecovery
93.54K Popularity
#
US-IranTalksVSTroopBuildup
765.16K Popularity
#
USStocksHitRecordHighs
1.19M Popularity
#
WCTCTradingChallengeShare8MUSDT
622.34K Popularity

Sitemap

Tempest Therapeutics (NASDAQ: TPST) registers 8.27M shares for resale by sellers

Trending Topics

GatePreIPOsLaunchesWithSpaceX

CryptoMarketRecovery

US-IranTalksVSTroopBuildup

USStocksHitRecordHighs

WCTCTradingChallengeShare8MUSDT

Pin